Shares of pharma companies, Five-Star Business, ASK Automotive, ONGC and IDFC will be in focus on Thursday.India's apex drug regulatory body, the Central Drugs Standard Control Organisation, has flagged 53 drug samples for failing to meet quality standards, according to an NDTV report. Pharmaceutical companies including Sun Pharma Laboratories Ltd., Glenmark Pharmaceuticals Ltd., and Alkem Health Science Ltd. are implicated in this quality lapse, NDTV said, quoting CDSCO's August report.Five-Star Business Finance Ltd. holders will divest stake worth Rs 4,317 crore through a secondary block deal on Thursday. The issue has a lockup period of 12 months post-cross for selling shareholders.Kuldip Singh Rathee, the promoter of ASK Automotive Ltd., will offload a total of 6.05% stake worth Rs 516 crore through an offer for sale between Sept. 26 and Sept. 27. The orders for the OFS will be placed on both the BSE and NSE.The NSE Nifty 50 and BSE Sensex bounced back from earlier lows to close at record highs on Wednesday, marking the fourth consecutive session of gains for India's benchmark indices. HDFC Bank Ltd. and Axis Bank Ltd. contributed significantly to this upward momentum.The Nifty 50 finished up 63.75 points, or 0.25%, at 26,004.15, while the Sensex rose by 255.83 points, or 0.30%, closing at 85,169.87.Market sentiment remains strong, driven by robust liquidity, according to analysts. They have identified 25,875 as a key support level for the Nifty 50, while 84,750 serves as important support for the Sensex. Analysts also noted that if these levels hold, the Nifty could rally to 26,100-26,150, and the Sensex could climb to 85,500-85,700. Conversely, a dip below 25,875 or 84,750 could shift market sentiment.Analysts also highlighted that the Nifty has maintained its position above its short-term moving average, indicating continued strength in the market.Centre To Infuse Additional Rs 10,501 Crore Into ONGC Petro Additions Here Are The Stocks To Watch On ThursdayPharma Companies: India's apex drug regulatory body, the Central Drugs Standard Control Organisation, has flagged 53 drug samples for failing to meet quality standards. Major pharmaceutical companies, including Sun Pharma Laboratories Ltd., Glenmark Pharmaceuticals Ltd., and Alkem Health Science Ltd., are implicated in this quality lapse, according to the CDSCO's August report.Five-Star Business Finance: Holders of the company are looking to offload a 19.2% stake comprising 5.6 crore shares worth Rs 4,317 crore via a block deal at Rs 768 apiece. The deal has a lock-up period of 12 months for selling shareholders.ASK Automotive: The promoter is likely to sell up to a 6.05% stake via OFS, which will have a base offer of 5.5% and an oversubscription option of 0.5% at a floor price of offer set at Rs 433 per share. The offer will be open on Sept. 26-27.ONGC: The board approved Rs 10,501 crore investment in ONGC Petro additions.IDFC: NCLT approved the merger of IDFC financial holdings with IDFC and the resulting entity's merger into IDFC First Bank.Vedanta: The board is to consider the fourth interim dividend on Oct. 8.Hindustan Copper: The company approved the sale of the Malanjkhand copper ore tailing plant in Madhya Pradesh.Cipla: The company's UK-based arm has signed a pact to acquire a 6.9% stake held by Jiangsu Xidi Pharma in a China-based unit. Post-acquisition Jiangsu to become a wholly owned step-down subsidiary of the company.Zen Technologies: The company launched remote-controlled weapon and surveillance systems to strengthen India's defence capabilities.UNO Minda: The company arm is in a pact with Korea-based Hyundai Mobis to manufacture licensed products like speakers.Sun Pharma, Glemnark, Alkem Labs Under Scrutiny As CDSCO Flags 53 Drugs For Quality FailuresResearch ReportsDiffusion Engineers IPO - Issue Details, Financials, Strengths, Risks, Peer Comparison And More: Anand RathiInfosys - To Outperform Its Peers In Q2, With An Upside Risk To Its 3-4% FY25E Guidance: HDFC SecuritiesDiffusion Engineers IPO - Issue Details, Valuations, Strategies, Risks, Financials And More: DRChokseyPiramal Pharma - Setting Precedence For Profitable Growth: ICICI SecuritiesKRN Heat Exchanger IPO- Issue Details, Investment Rationale, Strategies, Financials, Risks & More: Anand RathiSBI Cards - Pain Nearing End But Not Over Yet: Motilal OswalMAS Financial - Prioritizing Profitability Over Growth, Geographic Expansion On The Card: Axis SecuritiesFive-Star Business Finance Holders To Divest Stake Worth Rs 4,317 Crore